The acquisition of Signature's diagnostic cytogenetic tests for genetic diseases will enhance PerkinElmer's molecular diagnostic testing portfolio.
"We believe [the FAP drug] is a product that the combined company could commercialize with a small specialty sales force [with] minimal sales and marketing infrastructure," MDRNA's President and CEO Michael French said this week.
The all-stock merger will combine the scientific informatics firms, with Accelrys CEO Max Carnecchia leading the merged entity.
The animal and food safety company Neogen bought the agricultural trait selection business to enhance its genomics-based diagnostics products.
Through the transaction, MDRNA will gain Cequent's orally delivered transkingdom RNAi technology, which involves using attenuated Escherichia coli to transcribe therapeutic shRNAs.
Luminex's acquisition of BSD Robotics will provide it with new technologies in automation and robotics in the field of dry sample handling.
Genetix will operate as a separate business unit within Danaher subsidiary Leica Microsystems.
The sale of the product lines to Bruker will clear the way for Agilent to complete its $1.5 billion acquisition of Varian, which is now expected by the end of April.
Thermo completed the acquisition of the Finland-based maker of reagents, consumables, kits, and instruments for molecular biology applications.
The $7.2 billion deal would create a life sciences tools and pharmaceutical firm with annual revenues of nearly $3 billion.
The University of California, Berkeley's Jennifer Doudna reflects at Science on the anniversary of the announcement of the birth of twin girls who underwent genome editing.
By studying its enamel proteome, researchers have found the ancient ape Gigantopithecus blacki belongs to a sister clade to that of orangutans.
Bloomberg Businessweek discusses genomics with BGI's Wang Jian.
In Science this week: researchers find transplanting the gut microbiome in mice affects physiology, and more.